{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T21:23:44Z","timestamp":1795209824840,"version":"4.10.3"},"reference-count":162,"publisher":"Bentham Science Publishers Ltd.","issue":"1","funder":[{"DOI":"10.13039\/501100004561","name":"Ministry of Education and Science of the Republic of Kazakhstan","doi-asserted-by":"publisher","award":["AP13068269"],"award-info":[{"award-number":["AP13068269"]}],"id":[{"id":"10.13039\/501100004561","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CSCR"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Skin and subcutaneous tissue diseases (SSTDs) are a leading cause of nonfatal disability\nworldwide, particularly in resource-poor regions, affecting over one-third of the world's population.\nCurrent treatments for SSTDs include topical and oral medications, as well as mechanotherapy; however,\nthese approaches have several significant limitations, including insufficient efficacy, side effects,\nand high costs. In this regard, particular interest is directed to mesenchymal stem cell-derived\nexosomes (MSC-Exo), the therapeutic properties of which have been actively studied worldwide in\nrecent years. Our aim was to review clinical trials, published clinical studies, and case reports on\nMSC-Exo-based cell-free therapy for SSTDs, summarizing both its opportunities and challenges for\nclinical translation. A literature search for clinical studies and case reports of the application of MSCExo\nin the treatment of SSTDs was conducted using PubMed, Google Scholar databases, and ClinicalTrials.\ngov. The analysis revealed that MSC-Exo are utilized in treating diverse SSTDs, including:\nalopecia and hair thinning, psoriasis, facial redness in patients with atopic dermatitis, sensitive skin,\nmelasma, skin wounds, ulcers and burns, skin aging, hyperpigmentation, scars, and dystrophic epidermolysis\nbullosa. Ongoing clinical trials and preliminary published clinical studies and case reports\ndemonstrate that MSC-Exo are safe and effective cell-free therapeutic agents, highlighting their potential\nas a novel treatment for SSTDs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/011574888x393159250704132425","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T05:00:10Z","timestamp":1752555610000},"page":"47-65","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Mesenchymal Stem Cell-derived Exosomes in the Treatment of Skin and Subcutaneous Tissue Diseases: A Review"],"prefix":"10.2174","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1529-8471","authenticated-orcid":true,"given":"Aidar","family":"Dairov","sequence":"first","affiliation":[{"name":"Stem Cell Laboratory, National Center for Biotechnology, Astana, 010000, Kazakhstan"},{"name":"Department of GeneralBiology and Genomics, L.N. Gumilyov Eurasian National University, Astana, 010008, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8844-2510","authenticated-orcid":true,"given":"Assel","family":"Issabekova","sequence":"additional","affiliation":[{"name":"Stem Cell Laboratory, National Center for Biotechnology, Astana, 010000, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5029-5255","authenticated-orcid":true,"given":"Vyacheslav","family":"Ogay","sequence":"additional","affiliation":[{"name":"Stem Cell Laboratory, National Center for Biotechnology, Astana, 010000, Kazakhstan"},{"name":"Department of GeneralBiology and Genomics, L.N. Gumilyov Eurasian National University, Astana, 010008, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.22034\/ircmj.2024.469542.1331","volume":"59","author":"Darjani A.","year":"2024","unstructured":"Darjani A.; Rad E.H.; Ghahdarijani A.H.; Nejad K.G.; Economic burden of skin diseases among hospitalized patients in North of Iran. Iran Red Crescent Med J  2024,59,1-6","journal-title":"Iran Red Crescent Med J"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/bjd.19704","volume":"184","author":"Flohr C.","year":"2021","unstructured":"Flohr C.; Hay R.; Putting the burden of skin diseases on the global map. Br J Dermatol  2021,184(2),189-190","journal-title":"Br J Dermatol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1001\/jamadermatol.2016.5538","volume":"153","author":"Karimkhani C.","year":"2017","unstructured":"Karimkhani C.; Dellavalle R.P.; Coffeng L.E.; Global skin disease morbidity and mortality: an update from the Global Burden of Disease Study 2013. JAMA Dermatol  2017,153(5),406-412","journal-title":"JAMA Dermatol"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1007\/s13671-017-0192-7","volume":"6","author":"Seth D.","year":"2017","unstructured":"Seth D.; Cheldize K.; Brown D.; Freeman E.E.; Global burden of skin disease: Inequities and innovations. Curr Dermatol Rep  2017,6(3),204-210","journal-title":"Curr Dermatol Rep"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1111\/jdv.18050","volume":"36","author":"Richard M.A.","year":"2022","unstructured":"Richard M.A.; Paul C.; Nijsten T.; Prevalence of most common skin diseases in Europe: A population\u2010based study. J Eur Acad Dermatol Venereol  2022,36(7),1088-1096","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jdin.2020.10.006","volume":"2","author":"Urban K.","year":"2021","unstructured":"Urban K.; Chu S.; Giesey R.L.; Burden of skin disease and associated socioeconomic status in Asia: A cross-sectional analysis from the Global Burden of Disease Study 1990-2017. JAAD Int  2021,2,40-50","journal-title":"JAAD Int"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1586\/erp.09.23","volume":"9","author":"Basra M.K.A.","year":"2009","unstructured":"Basra M.K.A.; Shahrukh M.; Burden of skin diseases. Expert Rev Pharmacoecon Outcomes Res  2009,9(3),271-283","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"1145513","DOI":"10.3389\/fpubh.2023.1145513","volume":"11","author":"Yakupu A.","year":"2023","unstructured":"Yakupu A.; Aimaier R.; Yuan B.; The burden of skin and subcutaneous diseases: Findings from the global burden of disease study 2019. Front Public Health  2023,11,1145513","journal-title":"Front Public Health"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1038\/jid.2014.530","volume":"135","author":"Dalgard F.J.","year":"2015","unstructured":"Dalgard F.J.; Gieler U.; Tomas-Aragones L.; The psychological burden of skin diseases: A cross-sectional multicenter study among dermatological out-patients in 13 European countries. J Invest Dermatol  2015,135(4),984-991","journal-title":"J Invest Dermatol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3390\/physiologia4010005","volume":"4","author":"Ebrahimnejad N.","year":"2024","unstructured":"Ebrahimnejad N.; Jaafar D.; Goodarzi H.; The past, present, future: Pathophysiology, diagnosis, and treatment of human skin diseases. Physiologia  2024,4(1),81-99","journal-title":"Physiologia"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.jaad.2022.11.044","volume":"88","author":"Kreher M.A.","year":"2023","unstructured":"Kreher M.A.; Noland M.M.B.; Konda S.; Longo M.I.; Valdes-Rodriguez R.; Risk of melanoma and nonmelanoma skin cancer with immunosuppressants, part I: Calcineurin inhibitors, thiopurines, IMDH inhibitors, mTOR inhibitors, and corticosteroids. J Am Acad Dermatol  2023,88(3),521-530","journal-title":"J Am Acad Dermatol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/odi.12366","volume":"22","author":"Vangipuram R.","year":"2016","unstructured":"Vangipuram R.; Feldman S.R.; Ultraviolet phototherapy for cutaneous diseases: A concise review. Oral Dis  2016,22(4),253-259","journal-title":"Oral Dis"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13287-018-0791-7","volume":"9","author":"Keshtkar S.","year":"2018","unstructured":"Keshtkar S.; Azarpira N.; Ghahremani M.H.; Mesenchymal stem cell-derived extracellular vesicles: Novel frontiers in regenerative medicine. Stem Cell Res Ther  2018,9(1),63","journal-title":"Stem Cell Res Ther"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1177\/0963689719837897","volume":"28","author":"Musia\u0142-Wysocka A.","year":"2019","unstructured":"Musia\u0142-Wysocka A.; Kot M.; Majka M.; The pros and cons of mesenchymal stem cell-asbed therapies. Cell Transplant  2019,28(7),801-812","journal-title":"Cell Transplant"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/3057624","volume":"2018","author":"Wang M.","year":"2018","unstructured":"Wang M.; Yuan Q.; Xie L.; Mesenchymal stem cell-based immunomodulation: Properties and clinical application. Stem Cells Int  2018,2018,1-12","journal-title":"Stem Cells Int"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.jcyt.2021.01.001","volume":"23","author":"Gimona M.","year":"2021","unstructured":"Gimona M.; Brizzi M.F.; Choo A.B.H.; Critical considerations for the development of potency tests for therapeutic applications of mesenchymal stromal cell-derived small extracellular vesicles. Cytotherapy  2021,23(5),373-380","journal-title":"Cytotherapy"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1186\/s13287-021-02629-7","volume":"12","author":"Sun Y.","year":"2021","unstructured":"Sun Y.; Liu G.; Zhang K.; Cao Q.; Liu T.; Li J.; Mesenchymal stem cells-derived exosomes for drug delivery. Stem Cell Res Ther  2021,12(1),561","journal-title":"Stem Cell Res Ther"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.3390\/ph15101247","volume":"15","author":"Hastuti S.","year":"2022","unstructured":"Hastuti S.; Idroes R.; Imran I.; Ramli Y.; Abas A.H.; Tallei T.E.; hUMSC vs. hUMSC\u2013Exosome: Which one is better for epilepsy? Pharmaceuticals  2022,15(10),1247","journal-title":"Pharmaceuticals"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/s41392-023-01704-0","volume":"9","author":"Tan F.","year":"2024","unstructured":"Tan F.; Li X.; Wang Z.; Li J.; Shahzad K.; Zheng J.; Clinical applications of stem cell-derived exosomes. Signal Transduct Target Ther  2024,9(1),17","journal-title":"Signal Transduct Target Ther"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.jcyt.2017.11.002","volume":"20","author":"Wu P.","year":"2018","unstructured":"Wu P.; Zhang B.; Shi H.; Qian H.; Xu W.; MSC-exosome: A novel cell-free therapy for cutaneous regeneration. Cytotherapy  2018,20(3),291-301","journal-title":"Cytotherapy"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"809","DOI":"10.4149\/neo_2017_601","volume":"64","author":"Altanerova U.","year":"2017","unstructured":"Altanerova U.; Jakubechova J.; Repiska V.; Altaner C.; Exosomes of human mesenchymal stem\/stromal\/medicinal signaling cells. Neoplasma  2017,64(6),809-815","journal-title":"Neoplasma"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.3390\/cells13231956","volume":"13","author":"Yadav S.","year":"2024","unstructured":"Yadav S.; Maity P.; Kapat K.; The opportunities and challenges of mesenchymal stem cells-derived exosomes in theranostics and regenerative medicine. Cells  2024,13(23),1956","journal-title":"Cells"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.3390\/biom14111351","volume":"14","author":"Dairov A.","year":"2024","unstructured":"Dairov A.; Sekenova A.; Alimbek S.; Psoriasis: The versatility of mesenchymal stem cell and exosome therapies. Biomolecules  2024,14(11),1351","journal-title":"Biomolecules"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1007\/s11427-016-0240-4","volume":"59","author":"Ti D.","year":"2016","unstructured":"Ti D.; Hao H.; Fu X.; Han W.; Mesenchymal stem cells-derived exosomal microRNAs contribute to wound inflammation. Sci China Life Sci  2016,59(12),1305-1312","journal-title":"Sci China Life Sci"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1177\/0963689717723016","volume":"27","author":"Cavallini C.","year":"2018","unstructured":"Cavallini C.; Zannini C.; Olivi E.; Restoring in vivo-like membrane lipidomics promotes exosome trophic behavior from human placental mesenchymal stromal\/stem cells. Cell Transplant  2018,27(1),55-69","journal-title":"Cell Transplant"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"e13586","DOI":"10.1111\/cpr.13586","volume":"57","author":"Li X.","year":"2024","unstructured":"Li X.; Zhang D.; Yu Y.; Wang L.; Zhao M.; Umbilical cord\u2010derived mesenchymal stem cell secretome promotes skin regeneration and rejuvenation: From mechanism to therapeutics. Cell Prolif  2024,57(4),e13586","journal-title":"Cell Prolif"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"4597","DOI":"10.3390\/ijms20184597","volume":"20","author":"Eleuteri S.","year":"2019","unstructured":"Eleuteri S.; Fierabracci A.; Insights into the secretome of mesenchymal stem cells and its potential applications. Int J Mol Sci  2019,20(18),4597","journal-title":"Int J Mol Sci"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/nri855","volume":"2","author":"Th\u00e9ry C.","year":"2002","unstructured":"Th\u00e9ry C.; Zitvogel L.; Amigorena S.; Exosomes: composition, biogenesis and function. Nat Rev Immunol  2002,2(8),569-579","journal-title":"Nat Rev Immunol"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"eaau6977","DOI":"10.1126\/science.aau6977","volume":"367","author":"Kalluri R.","year":"2020","unstructured":"Kalluri R.; LeBleu V.S.; The biology, function, and biomedical applications of exosomes. Science  2020,367(6478),eaau6977","journal-title":"Science"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"112784","DOI":"10.1016\/j.ejmech.2020.112784","volume":"207","author":"Li M.","year":"2020","unstructured":"Li M.; Li S.; Du C.; Exosomes from different cells: Characteristics, modifications, and therapeutic applications. Eur J Med Chem  2020,207,112784","journal-title":"Eur J Med Chem"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1186\/s13287-020-01963-6","volume":"11","author":"Al-Khawaga S.","year":"2020","unstructured":"Al-Khawaga S.; Abdelalim E.M.; Potential application of mesenchymal stem cells and their exosomes in lung injury: An emerging therapeutic option for COVID-19 patients. Stem Cell Res Ther  2020,11(1),437","journal-title":"Stem Cell Res Ther"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"3232","DOI":"10.1016\/j.xphs.2022.08.016","volume":"111","author":"Koken G.Y.","year":"2022","unstructured":"Koken G.Y.; Abamor E.S.; Allahverdiyev A.; Karaoz E.; Wharton jelly derived mesenchymal stem cell\u2019s exosomes demonstrate significant antileishmanial and wound healing effects in combination with aloe-emodin: An in vitro study. J Pharm Sci  2022,111(12),3232-3242","journal-title":"J Pharm Sci"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jbiosc.2023.11.001","volume":"137","author":"Zhou Y.","year":"2024","unstructured":"Zhou Y.; Seo J.; Tu S.; Nanmo A.; Kageyama T.; Fukuda J.; Exosomes for hair growth and regeneration. J Biosci Bioeng  2024,137(1),1-8","journal-title":"J Biosci Bioeng"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3892\/br.2018.1054","volume":"8","author":"Liu Y.","year":"2018","unstructured":"Liu Y.; Wang H.; Wang J.; Exosomes as a novel pathway for regulating development and diseases of the skin (Review). Biomed Rep  2018,8(3),207-214","journal-title":"Biomed Rep"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13287-023-03287-7","volume":"14","author":"Lotfy A.","year":"2023","unstructured":"Lotfy A.; AboQuella N.M.; Wang H.; Mesenchymal stromal\/stem cell (MSC)-derived exosomes in clinical trials. Stem Cell Res Ther  2023,14(1),66","journal-title":"Stem Cell Res Ther"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1146\/annurev-cellbio-101512-122326","volume":"30","author":"Colombo M.","year":"2014","unstructured":"Colombo M.; Raposo G.; Th\u00e9ry C.; Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annu Rev Cell Dev Biol  2014,30(1),255-289","journal-title":"Annu Rev Cell Dev Biol"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"318","DOI":"10.4252\/wjsc.v14.i5.318","volume":"14","author":"Hu J.C.","year":"2022","unstructured":"Hu J.C.; Zheng C.X.; Sui B.D.; Liu W.J.; Jin Y.; Mesenchymal stem cell-derived exosomes: A novel and potential remedy for cutaneous wound healing and regeneration. World J Stem Cells  2022,14(5),318-329","journal-title":"World J Stem Cells"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"3177","DOI":"10.2147\/IJN.S407029","volume":"18","author":"Yuan Y.G.","year":"2023","unstructured":"Yuan Y.G.; Wang J.L.; Zhang Y.X.; Li L.; Reza A.M.M.T.; Gurunathan S.; Biogenesis, composition and potential therapeutic applications of mesenchymal stem cells derived exosomes in various diseases. Int J Nanomedicine  2023,18,3177-3210","journal-title":"Int J Nanomedicine"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1002\/stem.1771","volume":"33","author":"Zhang B.","year":"2015","unstructured":"Zhang B.; Wang M.; Gong A.; HucMSC-exosome mediated-Wnt4 signaling is required for cutaneous wound healing. Stem Cells  2015,33(7),2158-2168","journal-title":"Stem Cells"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"7047","DOI":"10.2147\/IJN.S433510","volume":"18","author":"Zhang H.","year":"2023","unstructured":"Zhang H.; Zang C.; Zhao W.; Exosome derived from mesenchymal stem cells alleviates hypertrophic scar by inhibiting the fibroblasts via TNFSF-13\/HSPG2 signaling pathway. Int J Nanomedicine  2023,18,7047-7063","journal-title":"Int J Nanomedicine"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s40779-023-00472-w","volume":"10","author":"Ding J.Y.","year":"2023","unstructured":"Ding J.Y.; Chen M.J.; Wu L.F.; Mesenchymal stem cell-derived extracellular vesicles in skin wound healing: Roles, opportunities and challenges. Mil Med Res  2023,10(1),36","journal-title":"Mil Med Res"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"933781","DOI":"10.3389\/fsurg.2022.933781","volume":"9","author":"Chen G.","year":"2022","unstructured":"Chen G.; Chen H.; Zeng X.; Zhu W.; Stem cell-derived exosomal transcriptomes for wound healing. Front Surg  2022,9,933781","journal-title":"Front Surg"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s13770-023-00542-z","volume":"20","author":"Ju C.","year":"2023","unstructured":"Ju C.; Liu D.; Exosomal microRNAs from mesenchymal stem cells: Novel therapeutic effect in wound healing. Tissue Eng Regen Med  2023,20(5),647-660","journal-title":"Tissue Eng Regen Med"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"379","DOI":"10.36347\/sjmcr.2024.v12i03.037","volume":"12","author":"Ghanbarzadeh A.","year":"2024","unstructured":"Ghanbarzadeh A.; Mehran Y.Z.; Weber M.; Exosome therapy in combination with photodynamic therapy for severe and large-scale injuries and resisted wound treatment: case series. Scholar J Med Case Report  2024,12(3),379-384","journal-title":"Scholar J Med Case Report"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"957","DOI":"10.2147\/CCID.S274370","volume":"13","author":"Cao G.","year":"2020","unstructured":"Cao G.; Chen B.; Zhang X.; Chen H.; Human adipose-derived mesenchymal stem cells-derived exosomal microRNA-19b promotes the healing of skin wounds through modulation of the CCL1\/TGF-\u03b2 signaling axis. Clin Cosmet Investig Dermatol  2020,13,957-971","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"485","DOI":"10.2147\/CCID.S284435","volume":"14","author":"Cardoso C.O.","year":"2021","unstructured":"Cardoso C.O.; Tolentino S.; Gratieri T.; Cunha-Filho M.; Lopez R.; Gelfuso G.; Topical treatment for scarring and non-scarring alopecia: An overview of the current evidence. Clin Cosmet Investig Dermatol  2021,14,485-499","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"93","DOI":"10.15406\/jdc.2021.05.00190","volume":"5","author":"Rambwawasvika H.","year":"2021","unstructured":"Rambwawasvika H.; Dzomba P.; Gwatidzo L.; Alopecia types, current and future treatment. J Dermatol Cosmetology  2021,5(4),93-99","journal-title":"J Dermatol Cosmetology"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S1471-4914(01)02027-5","volume":"7","author":"Cotsarelis G.","year":"2001","unstructured":"Cotsarelis G.; Millar S.E.; Towards a molecular understanding of hair loss and its treatment. Trends Mol Med  2001,7(7),293-301","journal-title":"Trends Mol Med"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"612","DOI":"10.3390\/pharmaceutics14030612","volume":"14","author":"Anudeep T.C.","year":"2022","unstructured":"Anudeep T.C.; Jeyaraman M.; Muthu S.; Advancing regenerative cellular therapies in non-scarring alopecia. Pharmaceutics  2022,14(3),612","journal-title":"Pharmaceutics"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/s40265-023-01880-x","volume":"83","author":"Devjani S.","year":"2023","unstructured":"Devjani S.; Ezemma O.; Kelley K.J.; Stratton E.; Senna M.; Androgenetic alopecia: Therapy update. Drugs  2023,83(8),701-715","journal-title":"Drugs"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s12020-017-1280-y","volume":"57","author":"Lolli F.","year":"2017","unstructured":"Lolli F.; Pallotti F.; Rossi A.; Androgenetic alopecia: A review. Endocrine  2017,57(1),9-17","journal-title":"Endocrine"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"5703","DOI":"10.3390\/ijms24065703","volume":"24","author":"Liang Y.","year":"2023","unstructured":"Liang Y.; Tang X.; Zhang X.; Cao C.; Yu M.; Wan M.; Adipose mesenchymal stromal cell-derived exosomes carrying MiR-122-5p antagonize the inhibitory effect of dihydrotestosterone on hair follicles by targeting the TGF-\u03b21\/SMAD3 signaling pathway. Int J Mol Sci  2023,24(6),5703","journal-title":"Int J Mol Sci"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.jdin.2023.07.005","volume":"13","author":"Ntshingila S.","year":"2023","unstructured":"Ntshingila S.; Oputu O.; Arowolo A.T.; Khumalo N.P.; Androgenetic alopecia: An update. JAAD Int  2023,13,150-158","journal-title":"JAAD Int"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"E228","DOI":"10.15167\/2421-4248\/jpmh2022.63.2s3.2765","volume":"63","author":"Gokce N","year":"2022","unstructured":"Gokce N; Basgoz N; Kenanoglu S; An overview of the genetic aspects of hair loss and its connection with nutrition.  J Prev Med Hyg  (Suppl. 3)2022,63(2),E228-38","journal-title":"J Prev Med Hyg"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s00266-024-04439-7","volume":"49","author":"Gentile P.","year":"2025","unstructured":"Gentile P.; Garcovich S.; Perego F.; Autologous micrografts containing nanovesicles, exosomes, and follicle stem cells in androgenetic alopecia: In vitro and in vivo analysis through a multicentric, observational, evaluator-blinded study. Aesthetic Plast Surg  2025,49(1),43-58","journal-title":"Aesthetic Plast Surg"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"4262","DOI":"10.1007\/s00266-024-04332-3","volume":"48","author":"Ersan M.","year":"2024","unstructured":"Ersan M.; Ozer E.; Akin O.; Tasli P.N.; Sahin F.; Effectiveness of exosome treatment in androgenetic alopecia: outcomes of a prospective study. Aesthetic Plast Surg  2024,48(21),4262-4271","journal-title":"Aesthetic Plast Surg"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.1111\/jocd.14846","volume":"21","author":"Park B.S.","year":"2022","unstructured":"Park B.S.; Choi H.I.; Huh G.; Kim W.S.; Effects of exosome from adipose\u2010derived stem cell on hair loss: A retrospective analysis of 39 patients. J Cosmet Dermatol  2022,21(5),2282-2284","journal-title":"J Cosmet Dermatol"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"312","DOI":"10.4252\/wjsc.v6.i3.312","volume":"6","author":"Tsuji W.","year":"2014","unstructured":"Tsuji W.; Rubin J.P.; Marra K.G.; Adipose-derived stem cells: Implications in tissue regeneration. World J Stem Cells  2014,6(3),312-321","journal-title":"World J Stem Cells"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"e15165","DOI":"10.1016\/j.heliyon.2023.e15165","volume":"9","author":"Norooznezhad A.H.","year":"2023","unstructured":"Norooznezhad A.H.; Yarani R.; Payandeh M.; Treatment of persistent chemotherapy-induced hair loss (Alopecia) with human mesenchymal stromal cells exosome enriched extracellular vesicles: A case report. Heliyon  2023,9(4),e15165","journal-title":"Heliyon"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/j.reth.2024.10.001","volume":"26","author":"Norouzi F.","year":"2024","unstructured":"Norouzi F.; Aghajani S.; Vosoughi N.; Exosomes derived stem cells as a modern therapeutic approach for skin rejuvenation and hair regrowth. Regen Ther  2024,26,1124-1137","journal-title":"Regen Ther"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/7471246","volume":"2022","author":"Li Y.","year":"2022","unstructured":"Li Y.; Wang G.; Wang Q.; Zhang Y.; Cui L.; Huang X.; Exosomes secreted from adipose-derived stem cells are a potential treatment agent for immune-mediated alopecia. J Immunol Res  2022,2022,1-14","journal-title":"J Immunol Res"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"15560","DOI":"10.1038\/s41598-017-15505-3","volume":"7","author":"Rajendran R.L.","year":"2017","unstructured":"Rajendran R.L.; Gangadaran P.; Bak S.S.; Extracellular vesicles derived from MSCs activates dermal papilla cell in vitro and promotes hair follicle conversion from telogen to anagen in mice. Sci Rep  2017,7(1),15560","journal-title":"Sci Rep"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jaut.2015.07.008","volume":"64","author":"Harden J.L.","year":"2015","unstructured":"Harden J.L.; Krueger J.G.; Bowcock A.M.; The immunogenetics of Psoriasis: A comprehensive review. J Autoimmun  2015,64,66-73","journal-title":"J Autoimmun"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/s41419-022-04523-3","volume":"13","author":"Zhou X.","year":"2022","unstructured":"Zhou X.; Chen Y.; Cui L.; Shi Y.; Guo C.; Advances in the pathogenesis of psoriasis: From keratinocyte perspective. Cell Death Dis  2022,13(1),81","journal-title":"Cell Death Dis"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"18","DOI":"10.23950\/jcmk\/14497","volume":"21","author":"Dairov A.","year":"2024","unstructured":"Dairov A.; Issabekova A.; Sekenova A.; Shakhatbayev M.; Ogay V.; Prevalence, incidence, gender and age distribution, and economic burden of psoriasis worldwide and in Kazakhstan. J Clin Med Kazakhstan  2024,21(2),18-30","journal-title":"J Clin Med Kazakhstan"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"16095","DOI":"10.3390\/ijms242216095","volume":"24","author":"Man A.M.","year":"2023","unstructured":"Man A.M.; Or\u0103san M.S.; Hoteiuc O.A.; Ol\u0103nescu-Vaida-Voevod M.C.; Mocan T.; Inflammation and psoriasis: A comprehensive review. Int J Mol Sci  2023,24(22),16095","journal-title":"Int J Mol Sci"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"201","DOI":"10.3892\/etm.2022.11124","volume":"23","author":"Branisteanu D.","year":"2022","unstructured":"Branisteanu D.; Cojocaru C.; Diaconu R.; Update on the etiopathogenesis of psoriasis (Review). Exp Ther Med  2022,23(3),201","journal-title":"Exp Ther Med"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12964-023-01381-0","volume":"22","author":"Liu S.","year":"2024","unstructured":"Liu S.; He M.; Jiang J.; Triggers for the onset and recurrence of psoriasis: A review and update. Cell Commun Signal  2024,22(1),108","journal-title":"Cell Commun Signal"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"156699","DOI":"10.1016\/j.cyto.2024.156699","volume":"182","author":"Chen Y.","year":"2024","unstructured":"Chen Y.; Mohamed A.H.; Amer Alsaiari A.; The role of mesenchymal stem cells in the treatment and pathogenesis of psoriasis. Cytokine  2024,182,156699","journal-title":"Cytokine"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"170","DOI":"10.7861\/clinmed.2021-0257","volume":"21","author":"Raharja A.","year":"2021","unstructured":"Raharja A.; Mahil S.K.; Barker J.N.; Psoriasis: a brief overview. Clin Med (Lond)  2021,21(3),170-173","journal-title":"Clin Med (Lond)"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"122915","DOI":"10.1016\/j.lfs.2024.122915","volume":"353","author":"Mohseni Meybodi M.A.","year":"2024","unstructured":"Mohseni Meybodi M.A.; Nilforoushzadeh M.A.; KhandanDezfully N, Mansouri P. The safety and efficacy of adipose tissue-derived exosomes in treating mild to moderate plaque psoriasis: A clinical study. Life Sci  2024,353,122915","journal-title":"Life Sci"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3390\/pharmaceutics17010051","volume":"17","author":"Chen Y.","year":"2025","unstructured":"Chen Y.; Liu H.; He Y.; Yang B.; Lu W.; Dai Z.; Roles for exosomes in the pathogenesis, drug delivery and therapy of psoriasis. Pharmaceutics  2025,17(1),51","journal-title":"Pharmaceutics"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s13555-021-00483-2","volume":"11","author":"Menter A.","year":"2021","unstructured":"Menter A.; Krueger G.G.; Paek S.Y.; Kivelevitch D.; Adamopoulos I.E.; Langley R.G.; Interleukin-17 and interleukin-23: A narrative review of mechanisms of action in psoriasis and associated comorbidities. Dermatol Ther (Heidelb)  2021,11(2),385-400","journal-title":"Dermatol Ther (Heidelb)"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.3390\/pharmaceutics16121586","volume":"16","author":"Tang B.","year":"2024","unstructured":"Tang B.; Bi Y.; Zheng X.; The role of extracellular vesicles in the development and treatment of psoriasis: narrative review. Pharmaceutics  2024,16(12),1586","journal-title":"Pharmaceutics"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1111\/all.13401","volume":"73","author":"Barbarot S.","year":"2018","unstructured":"Barbarot S.; Auziere S.; Gadkari A.; Epidemiology of atopic dermatitis in adults: Results from an international survey. Allergy  2018,73(6),1284-1293","journal-title":"Allergy"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S0140-6736(03)12193-9","volume":"361","author":"Leung D.Y.M.","year":"2003","unstructured":"Leung D.Y.M.; Bieber T.; Atopic dermatitis. Lancet  2003,361(9352),151-160","journal-title":"Lancet"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/S0140-6736(20)31286-1","volume":"396","author":"Langan S.M.","year":"2020","unstructured":"Langan S.M.; Irvine A.D.; Weidinger S.; Atopic dermatitis. Lancet  2020,396(10247),345-360","journal-title":"Lancet"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.alit.2021.10.002","volume":"71","author":"Murota H.","year":"2022","unstructured":"Murota H.; Koike Y.; Morisaki H.; Matsumoto M.; Takenaka M.; Exacerbating factors and disease burden in patients with atopic dermatitis. Allergol Int  2022,71(1),25-30","journal-title":"Allergol Int"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.3390\/ijms21082671","volume":"21","author":"Tamagawa-Mineoka R.","year":"2020","unstructured":"Tamagawa-Mineoka R.; Katoh N.; Atopic dermatitis: Identification and management of complicating factors. Int J Mol Sci  2020,21(8),2671","journal-title":"Int J Mol Sci"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1111\/jocd.14153","volume":"21","author":"Park K.Y.","year":"2022","unstructured":"Park K.Y.; Han H.S.; Park J.W.; Kwon H.H.; Park G.H.; Seo S.J.; Exosomes derived from human adipose tissue\u2010derived mesenchymal stem cells for the treatment of dupilumab\u2010related facial redness in patients with atopic dermatitis: A report of two cases. J Cosmet Dermatol  2022,21(2),844-849","journal-title":"J Cosmet Dermatol"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"2220444","DOI":"10.1080\/09546634.2023.2220444","volume":"34","author":"Han H.S.","year":"2023","unstructured":"Han H.S.; Koh Y.G.; Hong J.K.; Roh Y.J.; Seo S.J.; Park K.Y.; Adipose-derived stem cell exosomes for treatment of dupilumab-related facial redness in patients with atopic dermatitis. J Dermatolog Treat  2023,34(1),2220444","journal-title":"J Dermatolog Treat"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.jdin.2024.01.002","volume":"15","author":"Metko D.","year":"2024","unstructured":"Metko D.; Alkofide M.; Abu-Hilal M.; A real-world study of dupilumab in patients with atopic dermatitis including patients with malignancy and other medical comorbidities. JAAD Int  2024,15,5-11","journal-title":"JAAD Int"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"647012","DOI":"10.3389\/fcell.2021.647012","volume":"9","author":"Qui\u00f1ones-Vico M.I.","year":"2021","unstructured":"Qui\u00f1ones-Vico M.I.; Sanabria-de la Torre R.; S\u00e1nchez-D\u00edaz M.; The role of exosomes derived from mesenchymal stromal cells in dermatology. Front Cell Dev Biol  2021,9,647012","journal-title":"Front Cell Dev Biol"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"8904","DOI":"10.1038\/s41598-023-34418-y","volume":"13","author":"Shi C.","year":"2023","unstructured":"Shi C.; Pei S.; Ding Y.; Exosomes with overexpressed miR 147a suppress angiogenesis and infammatory injury in an experimental model of atopic dermatitis. Sci Rep  2023,13(1),8904","journal-title":"Sci Rep"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"1307455","DOI":"10.3389\/fimmu.2023.1307455","volume":"14","author":"Zhang R.","year":"2023","unstructured":"Zhang R.; Wei Y.; Wang T.; Exosomal miRNAs in autoimmune skin diseases. Front Immunol  2023,14,1307455","journal-title":"Front Immunol"},{"key":"ref=86","first-page":"130","volume":"158","author":"Saint-Martory C.","year":"2008","unstructured":"Saint-Martory C.; Roguedas-Contios A.M.; Sibaud V.; Degouy A.; Schmitt A.M.; Misery L.; Sensitive skin is not limited to the face. Br J Dermatol  2008,158(1),130-133","journal-title":"Br J Dermatol"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/jdv.17903","volume":"36","author":"Wollenberg A","year":"2022","unstructured":"Wollenberg A; Gim\u00e9nez-Arnau A.; Sensitive skin: A relevant syndrome, be aware J Eur Acad Dermatol Venereol  (Suppl. 5)2022,36(S5),3-5","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/j.1468-2494.2012.00754.x","volume":"35","author":"Berardesca E.","year":"2013","unstructured":"Berardesca E.; Farage M.; Maibach H.; Sensitive skin: An overview. Int J Cosmet Sci  2013,35(1),2-8","journal-title":"Int J Cosmet Sci"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"100015","DOI":"10.1016\/j.jdsct.2024.100015","volume":"1","author":"Jiang C.","year":"2024","unstructured":"Jiang C.; Guo C.; Yan J.; Sensitive skin syndrome: Research progress on mechanisms and applications. J Dermatol Sci Cosmetic Technol  2024,1(2),100015","journal-title":"J Dermatol Sci Cosmetic Technol"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"1053679","DOI":"10.3389\/fbioe.2022.1053679","volume":"10","author":"Ye C.","year":"2022","unstructured":"Ye C.; Zhang Y.; Su Z.; hMSC exosomes as a novel treatment for female sensitive skin: An in vivo study. Front Bioeng Biotechnol  2022,10,1053679","journal-title":"Front Bioeng Biotechnol"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"1337282","DOI":"10.3389\/fphar.2024.1337282","volume":"15","author":"Ghasemiyeh P.","year":"2024","unstructured":"Ghasemiyeh P.; Fazlinejad R.; Kiafar M.R.; Rasekh S.; Mokhtarzadegan M.; Mohammadi-Samani S.; Different therapeutic approaches in melasma: Advances and limitations. Front Pharmacol  2024,15,1337282","journal-title":"Front Pharmacol"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"450","DOI":"10.4103\/ijd.IJD_489_17","volume":"62","author":"Sarkar R.","year":"2017","unstructured":"Sarkar R.; Gokhale N.; Godse K.; Medical management of melasma: A review with consensus recommendations by Indian pigmentary expert group. Indian J Dermatol  2017,62(6),450","journal-title":"Indian J Dermatol"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.jaad.2023.07.1045","volume":"90","author":"Desai S.R.","year":"2024","unstructured":"Desai S.R.; Alexis A.F.; Elbuluk N.; Best practices in the treatment of melasma with a focus on patients with skin of color. J Am Acad Dermatol  2024,90(2),269-279","journal-title":"J Am Acad Dermatol"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1007\/s40257-024-00863-2","volume":"25","author":"Gan C.","year":"2024","unstructured":"Gan C.; Rodrigues M.; An update on new and existing treatments for the management of melasma. Am J Clin Dermatol  2024,25(5),717-733","journal-title":"Am J Clin Dermatol"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1111\/j.1468-3083.2009.03295.x","volume":"23","author":"Ortonne J.P.","year":"2009","unstructured":"Ortonne J.P.; Arellano I.; Berneburg M.; A global survey of the role of ultraviolet radiation and hormonal influences in the development of melasma. J Eur Acad Dermatol Venereol  2009,23(11),1254-1262","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1007\/s13555-022-00779-x","volume":"12","author":"Esp\u00f3sito A.C.C.","year":"2022","unstructured":"Esp\u00f3sito A.C.C.; Cassiano D.P.; da Silva C.N.; Update on melasma-part I: Pathogenesis. Dermatol Ther (Heidelb)  2022,12(9),1967-1988","journal-title":"Dermatol Ther (Heidelb)"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1002\/lsm.23628","volume":"55","author":"Wang T.","year":"2023","unstructured":"Wang T.; Gao H.; Wang D.; Stem cell\u2010derived exosomes in the treatment of melasma and its percutaneous penetration. Lasers Surg Med  2023,55(2),178-189","journal-title":"Lasers Surg Med"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"281","DOI":"10.36849\/JDD.C7395","volume":"23","author":"Peredo M.","year":"2024","unstructured":"Peredo M.; Shivananjappa S.; Topical human mesenchymal stem cell-derived exosomes for acceleration of wound healing following tissue trauma and aesthetic procedures: A case series. J Drugs Dermatol  2024,23(4),281-284","journal-title":"J Drugs Dermatol"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"tkad001","DOI":"10.1093\/burnst\/tkad001","volume":"11","author":"Chen W.","year":"2023","unstructured":"Chen W.; Wang Y.; Zheng J.; Characterization of cellular senescence in radiation ulcers and therapeutic effects of mesenchymal stem cell-derived conditioned medium. Burns Trauma  2023,11,tkad001","journal-title":"Burns Trauma"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1186\/s13287-024-04012-8","volume":"15","author":"Ghasempour A.","year":"2024","unstructured":"Ghasempour A.; Dehghan H.; Mahmoudi M.; Lavi Arab F.; Biomimetic scaffolds loaded with mesenchymal stem cells (MSCs) or MSC-derived exosomes for enhanced wound healing. Stem Cell Res Ther  2024,15(1),406","journal-title":"Stem Cell Res Ther"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"tkae021","DOI":"10.1093\/burnst\/tkae021","volume":"12","author":"Fakouri A.","year":"2024","unstructured":"Fakouri A.; Razavi Z.S.; Mohammed A.T.; Hussein A.H.A.; Afkhami H.; Hooshiar M.H.; Applications of mesenchymal stem cell-exosome components in wound infection healing: New insights. Burns Trauma  2024,12,tkae021","journal-title":"Burns Trauma"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"102611","DOI":"10.1016\/j.tice.2024.102611","volume":"91","author":"Esmaeili A.","year":"2024","unstructured":"Esmaeili A.; Noorkhajavi G.; Soleimani M.; Farsinezhad H.; Bagheri-Mohammadi S.; Keshel S.H.; Application of exosomes for the regeneration of skin wounds: Principles, recent applications and limitations. Tissue Cell  2024,91,102611","journal-title":"Tissue Cell"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1186\/s13287-022-02980-3","volume":"13","author":"Zhou Y.","year":"2022","unstructured":"Zhou Y.; Zhang X.L.; Lu S.T.; Human adipose-derived mesenchymal stem cells-derived exosomes encapsulated in pluronic F127 hydrogel promote wound healing and regeneration. Stem Cell Res Ther  2022,13(1),407","journal-title":"Stem Cell Res Ther"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"1256687","DOI":"10.3389\/fimmu.2023.1256687","volume":"14","author":"Qin X.","year":"2023","unstructured":"Qin X.; He J.; Wang X.; Wang J.; Yang R.; Chen X.; The functions and clinical application potential of exosomes derived from mesenchymal stem cells on wound repair: A review of recent research advances. Front Immunol  2023,14,1256687","journal-title":"Front Immunol"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1080\/10717544.2021.1912210","volume":"28","author":"Li Q.","year":"2021","unstructured":"Li Q.; Gong S.; Yao W.; Exosome loaded genipin crosslinked hydrogel facilitates full thickness cutaneous wound healing in rat animal model. Drug Deliv  2021,28(1),884-893","journal-title":"Drug Deliv"},{"key":"ref=106","doi-asserted-by":"publisher","DOI":"10.2174\/0113892010323495241016085000","author":"Heydari M.B.","unstructured":"Heydari M.B.; Ghanbari-Movahed Z.; Heydari M.; Farzaei M.H.; The exosome and its application in skin wound healing: a systematic review on in vitro studies. Curr Pharm Biotechnol  in press","journal-title":"Curr Pharm Biotechnol"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1097\/PRS.0000000000010083","volume":"151","author":"An Y.","year":"2023","unstructured":"An Y.; Huang F.; Tan X.; Exosomes of adipose tissue-derived stem cells promote wound healing by sponging miR-17-5p and inducing autophagy protein Ulk1. Plast Reconstr Surg  2023,151(5),1016-1028","journal-title":"Plast Reconstr Surg"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.biochi.2023.01.013","volume":"209","author":"Zakeri A.","year":"2023","unstructured":"Zakeri A.; Khaseb S.; Akhavan Rahnama M.; Hajaliaskari A.; Soufi Zomorrod M.; Exosomes derived from mesenchymal stem cells: A promising cell-free therapeutic tool for cutaneous wound healing. Biochimie  2023,209,73-84","journal-title":"Biochimie"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"2791","DOI":"10.3390\/biomedicines12122791","volume":"12","author":"Raghav P.K.","year":"2024","unstructured":"Raghav P.K.; Mann Z.; Nano-delivery revolution: Harnessing mesenchymal stem cell-derived exosomes\u2019 potential for wound healing. Biomedicines  2024,12(12),2791","journal-title":"Biomedicines"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"6218","DOI":"10.12998\/wjcc.v9.i22.6218","volume":"9","author":"Zeng Q.L.","year":"2021","unstructured":"Zeng Q.L.; Liu D.W.; Mesenchymal stem cell-derived exosomes: An emerging therapeutic strategy for normal and chronic wound healing. World J Clin Cases  2021,9(22),6218-6233","journal-title":"World J Clin Cases"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.smaim.2023.04.006","volume":"4","author":"Zhao X.","year":"2023","unstructured":"Zhao X.; Zhang W.; Fan J.; Chen X.; Wang X.; Application of mesenchymal stem cell exosomes in the treatment of skin wounds. Smart Mater Med  2023,4,578-589","journal-title":"Smart Mater Med"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"22","DOI":"10.2174\/1567205016666190809161115","volume":"13","author":"Chaudhary M.","year":"2020","unstructured":"Chaudhary M.; Khan A.; Gupta M.; Skin ageing: Pathophysiology and current market treatment approaches. Curr Aging Sci  2020,13(1),22-30","journal-title":"Curr Aging Sci"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1177\/0963689717725755","volume":"27","author":"Zhang S.","year":"2018","unstructured":"Zhang S.; Duan E.; Fighting against skin aging. Cell Transplant  2018,27(5),729-738","journal-title":"Cell Transplant"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"1195272","DOI":"10.3389\/fphys.2023.1195272","volume":"14","author":"Shin S.H.","year":"2023","unstructured":"Shin S.H.; Lee Y.H.; Rho N.K.; Park K.Y.; Skin aging from mechanisms to interventions: Focusing on dermal aging. Front Physiol  2023,14,1195272","journal-title":"Front Physiol"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"pbae004","DOI":"10.1093\/pcmedi\/pbae004","volume":"7","author":"Gui Q.","year":"2024","unstructured":"Gui Q.; Ding N.; Yao Z.; Extracellular vesicles derived from mesenchymal stem cells: The wine in Hebe\u2019s hands to treat skin aging. Precis Clin Med  2024,7(1),pbae004","journal-title":"Precis Clin Med"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"i17","DOI":"10.1093\/bjd\/ljad282","volume":"189","author":"Griffiths TW","year":"2023","unstructured":"Griffiths TW; Watson REB; Langton AK; Skin ageing and topical rejuvenation strategies. Br J Dermatol  (Suppl. 1)2023,189,i17-23","journal-title":"Br J Dermatol"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.29011\/2575-9760.001388","volume":"6","author":"Chernoff G.","year":"2021","unstructured":"Chernoff G.; The utilization of human placental mesenchymal stem cell derived exosomes in aging skin: An investigational pilot study. J Surg  2021,6,1388","journal-title":"J Surg"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/jocd.15695","volume":"22","author":"Chernoff G.","year":"2023","unstructured":"Chernoff G.;  Combining topical dermal infused exosomes with injected calcium hydroxylapatite for enhanced tissue biostimulation. J Cosmet Dermatol  (Suppl. 1)2023,22(S1),15-27","journal-title":"J Cosmet Dermatol"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"670","DOI":"10.3390\/medicina60040670","volume":"60","author":"Svolacchia F.","year":"2024","unstructured":"Svolacchia F.; Svolacchia L.; Falabella P.; Exosomes and signaling nanovesicles from the nanofiltration of preconditioned adipose tissue with Skin-B\u00ae in tissue regeneration and antiaging: A clinical study and case report. Medicina (Kaunas)  2024,60(4),670","journal-title":"Medicina (Kaunas)"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1007\/s13770-022-00461-5","volume":"19","author":"Wu J.Y.","year":"2022","unstructured":"Wu J.Y.; Wu S.N.; Zhang L.P.; Stem cell-derived exosomes: A new method for reversing skin aging. Tissue Eng Regen Med  2022,19(5),961-968","journal-title":"Tissue Eng Regen Med"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"1181308","DOI":"10.3389\/fimmu.2023.1181308","volume":"14","author":"Li J.","year":"2023","unstructured":"Li J.; Huang Y.; Sun H.; Yang L.; Mechanism of mesenchymal stem cells and exosomes in the treatment of age-related diseases. Front Immunol  2023,14,1181308","journal-title":"Front Immunol"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s43094-021-00284-6","volume":"7","author":"Rathee P.","year":"2021","unstructured":"Rathee P.; Kumar S.; Kumar D.; Kumari B.; Yadav S.S.; Skin hyperpigmentation and its treatment with herbs: An alternative method. Future J Pharm Sci  2021,7(1),132","journal-title":"Future J Pharm Sci"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1111\/pcmr.12986","volume":"34","author":"Nautiyal A.","year":"2021","unstructured":"Nautiyal A.; Wairkar S.; Management of hyperpigmentation: Current treatments and emerging therapies. Pigment Cell Melanoma Res  2021,34(6),1000-1014","journal-title":"Pigment Cell Melanoma Res"},{"key":"ref=124","doi-asserted-by":"publisher","DOI":"10.7573\/dic.2021-11-2","volume":"2022","author":"Moolla S.","year":"2021","unstructured":"Moolla S.; Miller-Monthrope Y.; Dermatology: How to manage facial hyperpigmentation in skin of colour. Drugs Context  2021,2022(11)","journal-title":"Drugs Context"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3390\/cosmetics7040090","volume":"7","author":"Cho B.S.","year":"2020","unstructured":"Cho B.S.; Lee J.; Won Y.; Skin brightening efficacy of exosomes derived from human adipose tissue-derived stem\/stromal cells: A prospective, split-face, randomized placebo-controlled study. Cosmetics  2020,7(4),90","journal-title":"Cosmetics"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1186\/s12951-023-02037-4","volume":"21","author":"Ding J.Y.","year":"2023","unstructured":"Ding J.Y.; Sun L.; Zhu Z.H.; Wu X.C.; Xu X.L.; Xiang Y.W.; Nano drug delivery systems: A promising approach to scar prevention and treatment. J Nanobiotechnology  2023,21(1),268","journal-title":"J Nanobiotechnology"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.3390\/ijms25031458","volume":"25","author":"Lin X.","year":"2024","unstructured":"Lin X.; Lai Y.; Scarring skin: Mechanisms and therapies. Int J Mol Sci  2024,25(3),1458","journal-title":"Int J Mol Sci"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"942756","DOI":"10.3389\/fmed.2022.942756","volume":"9","author":"Basson R.","year":"2022","unstructured":"Basson R.; Bayat A.; Skin scarring: Latest update on objective assessment and optimal management. Front Med (Lausanne)  2022,9,942756","journal-title":"Front Med (Lausanne)"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1089\/wound.2016.0696","volume":"7","author":"Marshall C.D.","year":"2018","unstructured":"Marshall C.D.; Hu M.S.; Leavitt T.; Barnes L.A.; Lorenz H.P.; Longaker M.T.; Cutaneous scarring: Basic science, current treatments, and future directions. Adv Wound Care (New Rochelle)  2018,7(2),29-45","journal-title":"Adv Wound Care (New Rochelle)"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"adv00310","DOI":"10.2340\/00015555-3666","volume":"100","author":"Kwon H.","year":"2020","unstructured":"Kwon H.; Yang S.; Lee J.; Combination treatment with human adipose tissue stem cell-derived exosomes and fractional CO2 laser for acne scars: A 12-week prospective, double-blind, randomized, split-face study. Acta Derm Venereol  2020,100(18),adv00310","journal-title":"Acta Derm Venereol"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.29011\/2575-9760.001482","volume":"7","author":"Chernoff G.","year":"2022","unstructured":"Chernoff G.; The utilization of human placental, fetal mesenchymal stem cell derived-exosomes in treating keloid scars. J Surg (Lisle)  2022,7(4),1482","journal-title":"J Surg (Lisle)"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1038\/ng.645","volume":"42","author":"Nakashima M.","year":"2010","unstructured":"Nakashima M.; Chung S.; Takahashi A.; A genome-wide association study identifies four susceptibility loci for keloid in the Japanese population. Nat Genet  2010,42(9),768-771","journal-title":"Nat Genet"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"2059513120940499","DOI":"10.1177\/2059513120940499","volume":"6","author":"Ojeh N.","year":"2020","unstructured":"Ojeh N.; Bharatha A.; Gaur U.; Forde A.L.; Keloids: Current and emerging therapies. Scars Burn Heal  2020,6,2059513120940499","journal-title":"Scars Burn Heal"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"360","DOI":"10.3389\/fcell.2020.00360","volume":"8","author":"Limandjaja G.C.","year":"2020","unstructured":"Limandjaja G.C.; Niessen F.B.; Scheper R.J.; Gibbs S.; The keloid disorder: Heterogeneity, histopathology, mechanisms and models. Front Cell Dev Biol  2020,8,360","journal-title":"Front Cell Dev Biol"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.clindermatol.2006.09.009","volume":"25","author":"Robles D.T.","year":"2007","unstructured":"Robles D.T.; Berg D.; Abnormal wound healing: Keloids. Clin Dermatol  2007,25(1),26-32","journal-title":"Clin Dermatol"},{"key":"ref=136","first-page":"33","volume":"13","author":"Betarbet U.","year":"2020","unstructured":"Betarbet U.; Blalock T.W.; Keloids: A review of etiology, prevention, and treatment. J Clin Aesthet Dermatol  2020,13(2),33-43","journal-title":"J Clin Aesthet Dermatol"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"9871","DOI":"10.2147\/IJN.S480901","volume":"19","author":"Gong X.","year":"2024","unstructured":"Gong X.; Zhao Q.; Zhang H.; The effects of mesenchymal stem cells-derived exosomes on metabolic reprogramming in scar formation and wound healing. Int J Nanomedicine  2024,19,9871-9887","journal-title":"Int J Nanomedicine"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"3643","DOI":"10.2147\/IJN.S412717","volume":"18","author":"Zhao W.","year":"2023","unstructured":"Zhao W.; Zhang H.; Liu R.; Cui R.; Advances in immunomodulatory mechanisms of mesenchymal stem cells-derived exosome on immune cells in scar formation. Int J Nanomedicine  2023,18,3643-3662","journal-title":"Int J Nanomedicine"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"275","DOI":"10.2147\/CCID.S54681","volume":"8","author":"Shinkuma S.","year":"2015","unstructured":"Shinkuma S.; Dystrophic epidermolysis bullosa: A review. Clin Cosmet Investig Dermatol  2015,8,275-284","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1111\/j.1600-0625.2008.00723.x","volume":"17","author":"Dang N.","year":"2008","unstructured":"Dang N.; Murrell D.F.; Mutation analysis and characterization of COL7A1 mutations in dystrophic epidermolysis bullosa. Exp Dermatol  2008,17(7),553-568","journal-title":"Exp Dermatol"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.clindermatol.2011.01.010","volume":"29","author":"Shinkuma S.","year":"2011","unstructured":"Shinkuma S.; McMillan J.R.; Shimizu H.; Ultrastructure and molecular pathogenesis of epidermolysis bullosa. Clin Dermatol  2011,29(4),412-419","journal-title":"Clin Dermatol"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"737272","DOI":"10.3389\/fgene.2021.737272","volume":"12","author":"Nystr\u00f6m A.","year":"2021","unstructured":"Nystr\u00f6m A.; Bruckner-Tuderman L.; Kiritsi D.; Dystrophic epidermolysis bullosa: Secondary disease mechanisms and disease modifiers. Front Genet  2021,12,737272","journal-title":"Front Genet"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1093\/bjd\/ljae182","volume":"191","author":"Samuelov L.","year":"2024","unstructured":"Samuelov L.; Dystrophic epidermolysis bullosa: From disease biology to biologic therapy. Br J Dermatol  2024,191(2),159-160","journal-title":"Br J Dermatol"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1007\/s13555-024-01227-8","volume":"14","author":"Danescu S.","year":"2024","unstructured":"Danescu S.; Negrutiu M.; Has C.; Treatment of epidermolysis bullosa and future directions: A review. Dermatol Ther (Heidelb)  2024,14(8),2059-2075","journal-title":"Dermatol Ther (Heidelb)"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.biochi.2018.04.007","volume":"155","author":"McBride J.D.","year":"2018","unstructured":"McBride J.D.; Rodriguez-Menocal L.; Candanedo A.; Guzman W.; Garcia-Contreras M.; Badiavas E.V.; Dual mechanism of type VII collagen transfer by bone marrow mesenchymal stem cell extracellular vesicles to recessive dystrophic epidermolysis bullosa fibroblasts. Biochimie  2018,155,50-58","journal-title":"Biochimie"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.3390\/ijms18061190","volume":"18","author":"Gimona M.","year":"2017","unstructured":"Gimona M.; Pachler K.; Laner-Plamberger S.; Schallmoser K.; Rohde E.; Manufacturing of human extracellular vesicle-based therapeutics for clinical use. Int J Mol Sci  2017,18(6),1190","journal-title":"Int J Mol Sci"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1146\/annurev-pharmtox-061616-030146","volume":"57","author":"Riazifar M.","year":"2017","unstructured":"Riazifar M.; Pone E.J.; L\u00f6tvall J.; Zhao W.; Stem cell extracellular vesicles: Extended messages of regeneration. Annu Rev Pharmacol Toxicol  2017,57(1),125-154","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"ref=148","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13287-021-02138-7","volume":"12","author":"Tang Y.","year":"2021","unstructured":"Tang Y.; Zhou Y.; Li H.J.; Advances in mesenchymal stem cell exosomes: A review. Stem Cell Res Ther  2021,12(1),71","journal-title":"Stem Cell Res Ther"},{"key":"ref=149","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/s44222-023-00064-2","volume":"1","author":"Zhang K.","year":"2023","unstructured":"Zhang K.; Cheng K.; Stem cell-derived exosome versus stem cell therapy. Nat Rev Bioeng  2023,1(9),608-609","journal-title":"Nat Rev Bioeng"},{"key":"ref=150","doi-asserted-by":"publisher","first-page":"6917","DOI":"10.2147\/IJN.S264498","volume":"15","author":"Zhang Y.","year":"2020","unstructured":"Zhang Y.; Bi J.; Huang J.; Tang Y.; Du S.; Li P.; Exosome: a review of its classification, isolation techniques, storage, diagnostic and targeted therapy applications. Int J Nanomedicine  2020,15,6917-6934","journal-title":"Int J Nanomedicine"},{"key":"ref=151","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1002\/stem.2575","volume":"35","author":"Phinney D.G.","year":"2017","unstructured":"Phinney D.G.; Pittenger M.F.; Concise review: MSC-derived exosomes for cell-free therapy. Stem Cells  2017,35(4),851-858","journal-title":"Stem Cells"},{"key":"ref=152","doi-asserted-by":"publisher","first-page":"2300584","DOI":"10.1002\/adhm.202300584","volume":"12","author":"Kronstadt S.M.","year":"2023","unstructured":"Kronstadt S.M.; Patel D.B.; Born L.J.; Mesenchymal stem cell culture within perfusion bioreactors incorporating 3D-printed scaffolds enables improved extracellular vesicle yield with preserved bioactivity. Adv Healthc Mater  2023,12(20),2300584","journal-title":"Adv Healthc Mater"},{"key":"ref=153","doi-asserted-by":"publisher","first-page":"180","DOI":"10.3760\/cma.j.issn.1009-2587.2017.03.013","volume":"33","author":"Li M.Y.","year":"2017","unstructured":"Li M.Y.; Liu D.W.; Mao Y.G.; Advances in the research of effects of exosomes derived from stem cells on wound repair. Zhonghua Shao Shang Za Zhi  2017,33(3),180-184","journal-title":"Zhonghua Shao Shang Za Zhi"},{"key":"ref=154","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1038\/mt.2015.44","volume":"23","author":"Rani S.","year":"2015","unstructured":"Rani S.; Ryan A.E.; Griffin M.D.; Ritter T.; Mesenchymal stem cell-derived extracellular vesicles: Toward cell-free therapeutic applications. Mol Ther  2015,23(5),812-823","journal-title":"Mol Ther"},{"key":"ref=155","doi-asserted-by":"publisher","first-page":"13974","DOI":"10.3390\/ijms232213974","volume":"23","author":"Ahmadi M.","year":"2022","unstructured":"Ahmadi M.; Mahmoodi M.; Shoaran M.; Nazari-Khanamiri F.; Rezaie J.; Harnessing normal and engineered mesenchymal stem cells derived exosomes for cancer therapy: Opportunity and challenges. Int J Mol Sci  2022,23(22),13974","journal-title":"Int J Mol Sci"},{"key":"ref=156","doi-asserted-by":"publisher","first-page":"3851","DOI":"10.1021\/acsami.2c20728","volume":"15","author":"Hade M.D.","year":"2023","unstructured":"Hade M.D.; Suire C.N.; Suo Z.; An effective peptide-based platform for efficient exosomal loading and cellular delivery of a microRNA. ACS Appl Mater Interfaces  2023,15(3),3851-3866","journal-title":"ACS Appl Mater Interfaces"},{"key":"ref=157","doi-asserted-by":"publisher","first-page":"7794","DOI":"10.3390\/ijms25147794","volume":"25","author":"Lee K.W.A.","year":"2024","unstructured":"Lee K.W.A.; Chan L.K.W.; Hung L.C.; Phoebe L.K.W.; Park Y.; Yi K.H.; Clinical applications of exosomes: A critical review. Int J Mol Sci  2024,25(14),7794","journal-title":"Int J Mol Sci"},{"key":"ref=158","doi-asserted-by":"publisher","first-page":"3119","DOI":"10.3390\/ijms19103119","volume":"19","author":"Kim S.","year":"2018","unstructured":"Kim S.; Lee S.; Kim H.; Kim T.; Exosomes secreted from induced pluripotent stem cell-derived mesenchymal stem cells accelerate skin cell proliferation. Int J Mol Sci  2018,19(10),3119","journal-title":"Int J Mol Sci"},{"key":"ref=159","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.reth.2024.01.009","volume":"25","author":"Long R.","year":"2024","unstructured":"Long R.; Wang S.; Exosomes from preconditioned mesenchymal stem cells: Tissue repair and regeneration. Regen Ther  2024,25,355-366","journal-title":"Regen Ther"},{"key":"ref=160","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1080\/07388551.2020.1805406","volume":"40","author":"Jafari D.","year":"2020","unstructured":"Jafari D.; Malih S.; Eini M.; Improvement, scaling-up, and downstream analysis of exosome production. Crit Rev Biotechnol  2020,40(8),1098-1112","journal-title":"Crit Rev Biotechnol"},{"key":"ref=161","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/1779346","volume":"2022","author":"Chen S.","year":"2022","unstructured":"Chen S.; Sun F.; Qian H.; Xu W.; Jiang J.; Preconditioning and engineering strategies for improving the efficacy of mesenchymal stem cell-derived exosomes in cell-free therapy. Stem Cells Int  2022,2022,1-18","journal-title":"Stem Cells Int"},{"key":"ref=162","doi-asserted-by":"publisher","first-page":"1609206","DOI":"10.1080\/20013078.2019.1609206","volume":"8","author":"Witwer K.W.","year":"2019","unstructured":"Witwer K.W.; Van Balkom B.W.M.; Bruno S.; Defining mesenchymal stromal cell (MSC)\u2010derived small extracellular vesicles for therapeutic applications. J Extracell Vesicles  2019,8(1),1609206","journal-title":"J Extracell Vesicles"}],"container-title":["Current Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/011574888X393159250704132425","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/243535\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/011574888X393159250704132425","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T08:00:54Z","timestamp":1778486454000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/243535\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":162,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/011574888x393159250704132425","relation":{},"ISSN":["1574-888X"],"issn-type":[{"value":"1574-888X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2025-02-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-20","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-09","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}